OraSure Technologies, Inc. Release: Oral Fluid Drug Testing Reveals More Heroin Use

BETHLEHEM, Pa., Jan. 26, 2011 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR), the market leader in oral fluid diagnostics, announced today that Quest Diagnostics Incorporated (NYSE:DGX) released new data indicating that oral fluid revealed approximately five times more heroin use in the general U.S. workforce than previously believed.

MORE ON THIS TOPIC